Law Offices of Thomas J. Lamb

  • About Firm
  • Practice Areas
  • Free Case Evaluation
  • Quick Contact Form
  • Frequently Asked Questions
  • Attorney Tom Lamb

No NAION Warnings: Ozempic, Wegovy, Mounjaro, and Zepbound

October 20, 2026 By Law Offices of Thomas J. Lamb, P.A.

Despite an increasing number of medical journal articles about non-arteritic anterior ischemic optic neuropathy NAION being linked to Ozempic, Wegovy, Mounjaro, and Zepbound, there are still no NAION warnings in the current drug labels here in the United States for these popular drugs. Here are a couple of recent Drug Injury Law articles … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Mounjaro, NAION warnings, Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), Ozempic, Wegovy, Zepbound

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call 910-256-2971 to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

910-256-2971

Main Navigation Menu

  • About Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

DrugInjuryLaw.com

DrugInjuryWatch.com

Asbestos-Mesothelioma.com

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971
TJL@LambLawOffice.com

  • Home
  • Disclaimer and Copyright Notices
  • Sitemap

Copyright © 2026 · Law Offices of Thomas J. Lamb, P.A.